[1]
L. M. M. Rosa and M. R. de Araújo Siega, “High-frequency migraine refractory to usual pharmacological treatment and antibody and responsive to full-spectrum cannabidiol: a case report”, Headache Med, vol. 13, no. 3, pp. 229–232, Sep. 2022.